These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8851590)

  • 1. Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.
    Beaulac C; Clément-Major S; Hawari J; Lagacé J
    Antimicrob Agents Chemother; 1996 Mar; 40(3):665-9. PubMed ID: 8851590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.
    Omri A; Beaulac C; Bouhajib M; Montplaisir S; Sharkawi M; Lagacé J
    Antimicrob Agents Chemother; 1994 May; 38(5):1090-5. PubMed ID: 8067743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolization of low phase transition temperature liposomal tobramycin as a dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosa.
    Beaulac C; Sachetelli S; Lagacé J
    J Drug Target; 1999; 7(1):33-41. PubMed ID: 10614813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.
    Alhariri M; Omri A
    Antimicrob Agents Chemother; 2013 Jan; 57(1):569-78. PubMed ID: 23147741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics.
    Price CI; Horton JW; Baxter CR
    Surgery; 1994 Apr; 115(4):480-7. PubMed ID: 8165539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and efficacies of liposomal and conventional formulations of tobramycin after intratracheal administration in rats with pulmonary Burkholderia cepacia infection.
    Marier JF; Lavigne J; Ducharme MP
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3776-81. PubMed ID: 12435676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.
    Omri A; Suntres ZE; Shek PN
    Biochem Pharmacol; 2002 Nov; 64(9):1407-13. PubMed ID: 12392822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats.
    Alipour M; Omri A; Lui EM; Suntres ZE
    Can J Physiol Pharmacol; 2013 Nov; 91(11):935-40. PubMed ID: 24117261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats.
    Marier JF; Brazier JL; Lavigne J; Ducharme MP
    J Antimicrob Chemother; 2003 Aug; 52(2):247-52. PubMed ID: 12837733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
    van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria.
    Beaulac C; Sachetelli S; Lagace J
    J Antimicrob Chemother; 1998 Jan; 41(1):35-41. PubMed ID: 9511035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms.
    Chiu AG; Antunes MB; Palmer JN; Cohen NA
    J Antimicrob Chemother; 2007 Jun; 59(6):1130-4. PubMed ID: 17405780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM; Waugh J; Noble S
    Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
    J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.
    Sabet M; Miller CE; Nolan TG; Senekeo-Effenberger K; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3923-8. PubMed ID: 19528273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
    Ratjen F; Döring G; Nikolaizik WH
    Lancet; 2001 Sep; 358(9286):983-4. PubMed ID: 11583754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.